Opus Genetics (IRD) Receivables (2021 - 2026)
Opus Genetics (IRD) recorded Receivables of $1.04 million in Q2 2026, down 69.4% from $3.4 million a year earlier and down 39.9% from the prior quarter.
Powered by 
Analysis
Opus Genetics (IRD) Receivables (2021 - 2026) Analysis & Trends
At the end of FY2025, Opus Genetics reported Receivables of $2 million, down 44.0% from FY2024.
- Annual Receivables has a three-year compound annual growth rate of 15.4% (FY2022 to FY2025).
- Across earlier years, Receivables came in at $3.56 million in FY2024 (+284.8%), $926,000 in FY2023 (-28.7%) and $1.3 million in FY2022.
- The Q2 2026 figure is the lowest quarterly Receivables since Q4 2023.
- On a year-over-year basis, Receivables has declined for three consecutive quarters, with growth averaging 39.2% over the last eight quarters.
- Peak year-over-year performance for Receivables in the last five years was growth of 905.9% in Q2 2024, against a decline of 81.7% in Q3 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.73 million (Q1 2026), $2 million (Q4 2025) and $2.92 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 2.13 Bn |
| 10 | Opus Genetics | 417.37 Mn | 192.65 Mn | - | 1.04 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.04 Mn |
| Mar 31, 2026 | 1.73 Mn |
| Dec 31, 2025 | 2.00 Mn |
| Sep 30, 2025 | 2.92 Mn |
| Jun 30, 2025 | 3.40 Mn |
| Mar 31, 2025 | 3.08 Mn |
| Dec 31, 2024 | 3.56 Mn |
| Sep 30, 2024 | 1.86 Mn |
| Jun 30, 2024 | 1.36 Mn |
| Mar 31, 2024 | 1.92 Mn |
| Dec 31, 2023 | 926,000.00 |
| Sep 30, 2023 | 10.13 Mn |
| Jun 30, 2023 | 135,000.00 |
| Mar 31, 2023 | 2.83 Mn |
| Dec 31, 2022 | 1.30 Mn |
| Jun 30, 2021 | 50,000.00 |
API Access
Opus Genetics Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=IRD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "IRD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=IRD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();